Navigation Links
Seminar Spotlights Key Trends in Biologics and Biosimilars
Date:3/12/2013

BURLINGTON, Mass., March 12, 2013 /PRNewswire/ -- Decision Resources Group (DRG) invites pharmaceutical professionals to a one-day seminar of in-depth analysis covering key issues in the biologics and biosimilars market. The seminar, which will include presentations from prominent DRG analysts and an industry panel discussion, will be held May 2, 2013 at Hotel Solamar in San Diego, CA.

(Logo: http://photos.prnewswire.com/prnh/20130103/MM36768LOGO )

Andrew Merron , Ph.D., Director of the Biosimilars Advisory Service at Decision Resources Group, a recognized expert in the area of biologics and biosimilars, explained the timeliness of the seminar. "Though the first generation of biosimilar products experienced mixed commercial success in Europe, substantial commercial opportunity remains for future biosimilar agents across a wide variety of indications and new biologics continue to carve out niches and evolve current standards of care,"  said Dr. Merron.

Presentations at the seminar will address market trends and opportunities. Dr. Merron noted, "Sales of biologics have continued to grow globally despite increasing competition from biosimilars. However, developers of new branded biologics are now challenged to demonstrate clinical differentiation and developers of biosimilars are challenged to meet robust clinical comparability requirements."

This seminar is intended for pharmaceutical professionals involved in market research, business development and competitive intelligence.  Attendees are invited to engage with analysts and peers with a post-event reception

For more information about the topics and speakers at the seminar go to http://www.competitivelandscapeseries.com/biologics-and-biosimilars/index.html   

Media Contact
Media interested in further information or in attending the seminar should contact Roy Strunin at rstrunin@dresources.com or (781) 993-2515.

About the Competitive Landscape Seminar Series
The Competitive Landscape Seminar Series: Biologics and Biosimilars will be held on May 2, 2013. This high-value, one-day seminar has been developed specifically for biopharmaceutical market research executives as well as biologics and biosimilars product teams. Expert analysts from Decision Resources Group companies—Decision Resources and BioTrends Research Group—will share their latest research findings on key biologics and biosimilars trends.

About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

Decision Resources Group
Roy Strunin
781-993-2515
rstrunin@dresources.com


'/>"/>
SOURCE Decision Resources Group
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. iBioSeminars and iBioMagazine: Free, Online Biology Seminars and Short Talks by Leading Scientists
2. ComplianceOnline Announces Seminar on Clinical Trial Project Supplier Quality Improvement
3. ComplianceOnline Announces Seminar on Statistical Analysis for Product Development
4. Patheon to Host Complimentary Seminar on “Getting Your Drug through Phase I Early Development Effectively” at Milton Park, UK Facility
5. BioSpace Spotlights Northwests Life Science Community
6. BioSpace Spotlights Leading Life Science Community
7. FasterCures Spotlights Addario Lung Cancer Medical Institutes Innovative Research Programs
8. BioSpace Spotlights the growing Midwest Life Science Community
9. BioSpace Spotlights Thriving Bay Area Life Science Community
10. BioSpace Spotlights Northwests Life Science Community
11. ResearchMoz: MicroRNA Market Trends 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... ... 2016 , ... The American Medical Informatics Association (AMIA) responded ... Coordinator for Health IT (ONC) outlining a measurement approach to interoperability that focuses ... and where it was needed. The organization of health informatics professionals said a ...
(Date:5/25/2016)... ... 25, 2016 , ... Biohaven Pharmaceutical Holding Company Ltd. (Biohaven) ... company’s orphan drug designation request covering BHV-4157 for the treatment of Spinocerebellar Ataxia ... , Spinocerebellar ataxia is a rare, debilitating neurodegenerative disorder that is estimated ...
(Date:5/24/2016)... ... May 24, 2016 , ... ... re-branded identity. The new Media Cybernetics corporate branding reflects a results-driven revitalization for ... and image analysis. The re-branding components include a crisp, refreshed logo and a ...
(Date:5/23/2016)... 2016 Oxitec CEO Hadyn Parry ... 10:15 a.m. ET before the United States House Committee on ... can play in controlling the spread of the Aedes ...      (Logo: http://photos.prnewswire.com/prnh/20150630/227348 ) ... self-limiting gene. Trials in Brazil , ...
Breaking Biology Technology:
(Date:3/14/2016)... NXTD ) ("NXT-ID" or the "Company"), a company ... of a new series of commercials on Time Warner Cable ... .  The commercials will air on Bloomberg TV, Fox Business ... show. --> NXTD ) ("NXT-ID" or the "Company"), ... the airing of a new series of commercials on Time ...
(Date:3/10/2016)... India , March 10, 2016 ... a new market research report "Identity and Access Management ... & Audit, Compliance, and Governance), by Organization Size, by ... to 2020", published by MarketsandMarkets, The market is estimated ... USD 12.78 Billion by 2020, at a Compound Annual ...
(Date:3/9/2016)... GARDENS, Fla. , March 9, 2016 /PRNewswire/ ... management authentication and enrollment solutions, today announced the ... DigitalPersona ® Altus multi-factor authentication platform. ... and InfoSec managers to step-up security where it,s ... Washington, DC . ...
Breaking Biology News(10 mins):